ENVERIC Trademark

Trademark Overview


On Tuesday, July 26, 2022, a trademark application was filed for ENVERIC with the United States Patent and Trademark Office. The USPTO has given the ENVERIC trademark a serial number of 97520334. The federal status of this trademark filing is REGISTERED as of Tuesday, October 10, 2023. This trademark is owned by Enveric Biosciences, Inc.. The ENVERIC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment; Anti-cancer preparations; Pharmaceutical products for the treatment of cancer

pharmaceutical research services; medical research services; medical research laboratory services; research and development of new products for others; research and development services, for the development of a portfolio of psychoactive compounds and derivatives targeted for the treatment of medical conditions and disorders; research and development services, for the development of a portfolio of compounds and derivatives targeted for the treatment of cancer and the side effects of cancer; providing online non-downloadable computer software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical data and treatment data, in the field of medical research; scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic st...
enveric

General Information


Serial Number97520334
Word MarkENVERIC
Filing DateTuesday, July 26, 2022
Status700 - REGISTERED
Status DateTuesday, October 10, 2023
Registration Number7186904
Registration DateTuesday, October 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and Servicespharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment; Anti-cancer preparations; Pharmaceutical products for the treatment of cancer
Goods and Servicespharmaceutical research services; medical research services; medical research laboratory services; research and development of new products for others; research and development services, for the development of a portfolio of psychoactive compounds and derivatives targeted for the treatment of medical conditions and disorders; research and development services, for the development of a portfolio of compounds and derivatives targeted for the treatment of cancer and the side effects of cancer; providing online non-downloadable computer software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical data and treatment data, in the field of medical research; scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; product development of pharmaceutical substances and medicines; pharmaceutical testing services; scientific laboratory services; research laboratory services relating to pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2022
Primary Code005
First Use Anywhere DateThursday, November 17, 2022
First Use In Commerce DateThursday, November 17, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2022
Primary Code042
First Use Anywhere DateThursday, November 17, 2022
First Use In Commerce DateThursday, November 17, 2022

Trademark Owner History


Party NameEnveric Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNaples, FL 34103

Party NameEnveric Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNaples, FL 34103

Party NameEnveric Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNaples, FL 34103

Trademark Events


Event DateEvent Description
Tuesday, October 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 16, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Saturday, May 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 13, 2023NON-FINAL ACTION E-MAILED
Saturday, May 13, 2023NON-FINAL ACTION WRITTEN
Saturday, May 13, 2023USE AMENDMENT ACCEPTED
Thursday, May 11, 2023ASSIGNED TO EXAMINER
Thursday, January 19, 2023AMENDMENT TO USE PROCESSING COMPLETE
Thursday, January 19, 2023USE AMENDMENT FILED
Wednesday, January 18, 2023TEAS AMENDMENT OF USE RECEIVED
Wednesday, August 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 29, 2022NEW APPLICATION ENTERED